Romboutsia timonensis

Information

Microbe Identification

Romboutsia timonensis

Microbe id: PMDBM2021690
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Romboutsia timonensis [1776391]
Taxonomy Genus: Romboutsia [1501226]
Taxonomy Family: n.a. [n.a.]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Romboutsia timonensis

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Romboutsia timonensis


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Romboutsia timonensis distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Romboutsia timonensis in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Romboutsia timonensis

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA648014🔗-3.3584330990028316S
Kidney Failure, Chronic PRJNA449784🔗-3.24854290437423mNGS
Kidney Failure, Chronic PRJNA449784🔗-3.22611938986258mNGS
Kidney Failure, Chronic PRJEB65297🔗-2.96541033788597mNGS
Kidney Failure, Chronic PRJEB65297🔗-2.92771323594133mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.38400204260838mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.28082030707031mNGS
Arthritis, Juvenile PRJNA562467🔗-3.2593365044010516S
Diabetes Mellitus, Type 2 PRJNA719138🔗-4.5821558927432716S
Diabetes Mellitus, Type 2 PRJNA646010🔗-4.0745365939560216S
Diabetes Mellitus, Type 2 PRJDB9608🔗-3.96571190091216S
Diarrhea PRJNA317326🔗-3.1885115347649416S
Colorectal Neoplasms PRJNA824020🔗-4.3457429524100516S
Colorectal Neoplasms PRJNA936589🔗-4.08025471407435mNGS
Colorectal Neoplasms PRJNA936589🔗-4.07949698795759mNGS
Colorectal Neoplasms PRJNA284542🔗-4.0252369923519416S
Colorectal Neoplasms PRJNA464414🔗-3.0908560650119116S
Colorectal Neoplasms PRJNA1167935🔗-2.56279005272369mNGS
Colorectal Neoplasms PRJNA1167935🔗-2.54513559854936mNGS
Colorectal Neoplasms PRJNA1138893🔗-2.10846789242383mNGS
Colorectal Neoplasms PRJNA1138893🔗-2.01034754087509mNGS
Colorectal Neoplasms PRJNA1050885🔗3.3183686622446mNGS
Colorectal Neoplasms PRJNA1050885🔗3.34295748979067mNGS
Colorectal Neoplasms PRJNA731589🔗3.55605531975475mNGS
Colorectal Neoplasms PRJNA731589🔗3.57850864079684mNGS
Respiratory Syncytial Virus Infections PRJNA579491🔗-2.870950578920116S
Tuberculosis PRJNA795263🔗-3.9724632434264416S
Spinal Cord Injuries PRJNA861246🔗-4.9169247891784316S
Osteoporosis, Postmenopausal PRJNA631117🔗-3.4685667948533916S
Carcinoma, Renal Cell PRJNA842560🔗4.0062694813501916S
Celiac Disease PRJNA385740🔗-4.5673072117257716S
Metabolic Syndrome PRJNA417579🔗3.8656498855833516S
Spondylarthritis PRJNA342486🔗-4.0394421826506616S
Caliciviridae Infections PRJNA788674🔗-4.3275331557765516S
Hepatolenticular Degeneration PRJNA1038771🔗3.7478111840455816S
Feeding and Eating Disorders PRJEB55035🔗-3.8799253069808816S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.2899134678886916S
Prostatic Neoplasms PRJNA762994🔗-3.680041358637816S
Crohn Disease PRJNA938107🔗-3.9445791515364616S
Crohn Disease PRJNA1156939🔗-3.5416069233096616S
Crohn Disease PRJNA813736🔗-3.07139920906098mNGS
Crohn Disease PRJNA820056🔗-3.0615243858234116S
Crohn Disease PRJNA813736🔗-2.99625319255484mNGS
Crohn Disease PRJNA993675🔗-2.32213332255027mNGS
Crohn Disease PRJNA993675🔗-2.19985497054259mNGS
Crohn Disease PRJNA398089🔗2.9827049401869mNGS
Crohn Disease PRJNA398089🔗3.03269485173621mNGS
Psoriasis PRJNA634145🔗-3.20420446380772mNGS
Psoriasis PRJNA634145🔗-3.11630953876212mNGS
Psoriasis PRJNA938297🔗3.69943776311375mNGS
Psoriasis PRJNA938297🔗3.79618737283395mNGS
Mastitis PRJNA667141🔗-3.980635317258316S
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗-2.80570949484279mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗-2.72535889840255mNGS
Cholestasis PRJNA478781🔗-3.3324213187618216S
Moyamoya Disease PRJNA917033🔗-3.6021942725463116S
Meningioma PRJNA626591🔗-4.1744749832576616S
Endometriosis PRJNA715328🔗-4.3184781065441216S
Diabetic Retinopathy PRJNA857030🔗-4.338298790769516S
Anorexia PRJNA674716🔗-3.08491825995176mNGS
Anorexia PRJNA674716🔗-2.94070697841848mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗-5.3962905321400816S
Cholangiocarcinoma PRJNA932948🔗-2.1313947328735mNGS
Cholangiocarcinoma PRJNA932948🔗-2.08116263520699mNGS
Neuroblastoma PRJEB63351🔗-2.8398605743936mNGS
Neuroblastoma PRJNA716780🔗-2.8290490277405mNGS
Neuroblastoma PRJEB63351🔗-2.76119913518612mNGS
Neuroblastoma PRJNA716780🔗-2.72812118115226mNGS
Hematologic Neoplasms PRJNA777832🔗-4.0374167203296216S
Digestive System Diseases PRJNA438404🔗-3.9359228008641416S
Myasthenia Gravis PRJNA688881🔗-2.41515479695999mNGS
Myasthenia Gravis PRJNA688881🔗-2.32253166267904mNGS
Irritable Bowel Syndrome PRJNA682378🔗3.3051747162584516S
Peutz-Jeghers Syndrome PRJNA545597🔗-3.6682222850722316S
Peutz-Jeghers Syndrome PRJNA905444🔗-3.35923086971484mNGS
Peutz-Jeghers Syndrome PRJNA905444🔗-3.35325212266112mNGS
IgA Deficiency PRJNA633381🔗-2.73860811594021mNGS
IgA Deficiency PRJNA633381🔗-2.70969621639209mNGS
Depressive Disorder, Major PRJNA762199🔗-3.02974444734109mNGS
Depressive Disorder, Major PRJNA943232🔗-2.93488292730186mNGS
Depressive Disorder, Major PRJNA762199🔗-2.92853143853195mNGS
Depressive Disorder, Major PRJNA943232🔗-2.90829271867232mNGS
Clostridium Infections PRJNA648321🔗-3.57755474690137mNGS
Clostridium Infections PRJNA648321🔗-3.5398826244309mNGS
Alzheimer Disease PRJEB51982🔗-4.1684204555140516S
Lung Neoplasms PRJNA507734🔗-4.2174376553335916S
Liver Cirrhosis PRJNA861246🔗-4.9275049712426916S
Cystic Fibrosis PRJNA314903🔗-2.53097223586214mNGS
Cystic Fibrosis PRJNA314903🔗-2.51998563356474mNGS
Obesity PRJNA1125836🔗2.87860729308763mNGS
Obesity PRJNA1125836🔗2.93493945530672mNGS
Diabetes Mellitus PRJNA400325🔗-4.3568120327815516S
HIV Infections PRJNA810567🔗-3.2831234729238716S
Fibromyalgia PRJEB80379🔗-3.18719779611392mNGS
Fibromyalgia PRJEB80379🔗-3.14901123355659mNGS
Amebiasis PRJNA608066🔗-3.6453755450385716S
Breast Neoplasms PRJNA383849🔗-3.1095837597663716S
Breast Neoplasms PRJNA658160🔗-3.0495887757548716S
COVID-19 PRJNA769052🔗-3.7956662749629816S
COVID-19 PRJNA907010🔗-3.588100175975516S
COVID-19 PRJNA689961🔗-3.09023859701779mNGS
COVID-19 PRJNA689961🔗-3.06564363895658mNGS
COVID-19 PRJNA624223🔗-2.76172421420841mNGS
COVID-19 PRJNA624223🔗-2.73192029533595mNGS
COVID-19 PRJDB13214🔗-2.32003853594965mNGS
COVID-19 PRJDB13214🔗-2.2465854038704mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Romboutsia timonensis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Romboutsia timonensis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Romboutsia timonensis

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Romboutsia timonensis


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Romboutsia timonensis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Romboutsia timonensis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Romboutsia timonensis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Romboutsia timonensis

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Romboutsia timonensis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Romboutsia timonensis


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Romboutsia timonensis


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?